Impact of a multi-professional expert team on EOL care of children with cancer

Pediatr Int. 2021 Dec;63(12):1451-1457. doi: 10.1111/ped.14626. Epub 2021 Nov 22.

Abstract

Background: The quality of end-of-life (Q-EOL) care is influenced by various factors such as resources for palliative care (PC). We introduced a multi-professional expert team (MET) in 2014, which provides home-based care for children and adolescents with incurable cancer. This study investigated the impacts of the outreach activities by the MET on Q-EOL care of pediatric oncology patients.

Methods: This observational study retrospectively examined 112 patients receiving end-of-life care between 1989 and 2018 at a pediatric cancer center in Japan. Some of the indicators of Q-EOL care before and after the introduction of the outreach activities by the MET were compared. The subjects were 92 in pre-MET and 20 in post-MET periods.

Results: The median number of days for which the patients stayed at home during the final seven or 30 days were significantly prolonged in the post-MET period (0.0 vs 1.5 days, P = 0.020, 3.0 vs 12.0 days, P = 0.042). The change was more significant in hematologic malignancies than solid and central nervous system tumors. Patients receiving longer PC before their deaths could stay at home longer during the last 7 days. The ratio of patients receiving PC for more than 2 months was significantly increased in post-MET period (60.9 vs 90.0%, P = 0.014). More patients also greeted their deaths at home in the post-MET period (3.3 vs 25.0%, P < 0.001).

Conclusions: The activities of the MET transformed the end-of-life care of children and adolescents with incurable cancer. Earlier transitions to PC from curative treatment were associated with longer home-based care and more deaths at home.

Keywords: end-of-life care; home-based care; multi-professional expert team; pediatric cancer; pediatric palliative care.

Publication types

  • Observational Study

MeSH terms

  • Adolescent
  • Central Nervous System Neoplasms*
  • Child
  • Hospice Care*
  • Humans
  • Neoplasms* / therapy
  • Palliative Care
  • Retrospective Studies
  • Terminal Care*